2'-deoxy-2'-methylenecytidine and docetaxel anhydrous

2'-deoxy-2'-methylenecytidine has been researched along with docetaxel anhydrous in 1 studies

Compound Research Comparison

Studies (2'-deoxy-2'-methylenecytidine)	Trials (2'-deoxy-2'-methylenecytidine)	Recent Studies (post-2010) (2'-deoxy-2'-methylenecytidine)	Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)
30	2	0	12,110	3,216	6,920

Protein Interaction Comparison

Protein	Taxonomy	2'-deoxy-2'-methylenecytidine (IC50)	docetaxel anhydrous (IC50)
Kinesin-like protein KIF11	Homo sapiens (human)		0.0014
Nucleotide-binding oligomerization domain-containing protein 2	Homo sapiens (human)		5.0119

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Friberg, LE; Henningsson, A; Karlsson, MO; Maas, H; Nguyen, L	1

Other Studies

1 other study(ies) available for 2'-deoxy-2'-methylenecytidine and docetaxel anhydrous

Article	Year
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Dec-15, Volume: 20, Issue:24 Topics: Antineoplastic Agents; Bone Marrow; Camptothecin; Deoxycytidine; Docetaxel; Etoposide; Humans; Irinotecan; Leukocytes; Models, Biological; Neutrophils; Paclitaxel; Taxoids; Vinblastine	2002

Article

Year

Model of chemotherapy-induced myelosuppression with parameter consistency across drugs.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Dec-15, Volume: 20, Issue:24

Topics: Antineoplastic Agents; Bone Marrow; Camptothecin; Deoxycytidine; Docetaxel; Etoposide; Humans; Irinotecan; Leukocytes; Models, Biological; Neutrophils; Paclitaxel; Taxoids; Vinblastine

2002